All lobbying filings

Forbes-Tate

Forbes-Tate filed a Q4 report for VIR Biotechnology, Inc. on January 17, 2026, reporting $50,000 in lobbying income.

Lobbying for VIR Biotechnology, Inc. · Clinical Stage immunology company

As filed: FORBES-TATE for VIR BIOTECHNOLOGY, INC.

All filings by Forbes-Tate · Everything VIR Biotechnology, Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 17, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Lobbyists on this filing 1

MICHAEL ALEXANDER WILLIAMS New on this filing

Previously held: Legislative Director, Rep. Lucy McBath (2021-2022); Legislative Assistant, Rep. Lucy McBath (2019-2020); Legislative Aide, Sen. Doug Jones (2019); Legislative Correspondent, Sen. Doug Jones (2018-2019)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to biopharmaceutical research, development, and manufacturing for infectious disease products.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.